In vivo inhibition of angiogenesis and induction of apoptosis by retinoic acid in squamous cell carcinoma

Clinical Cancer Research

Volumn 3, Issue 2, 1997, Pages 179-184

  Liaudet Coopman, Emmanuelle D E ^a   Berchem, Guy J ^a   Wellstein, Anton ^a,b  

^a GEORGETOWN UNIVERSITY   (United States)

^b Lombards Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL LINE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; KERATINOCYTES; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PROLIFERATING CELL NUCLEAR ANTIGEN; RNA, MESSENGER; TRETINOIN; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 0031035029     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Lippman, S. M., Kessler, J. F., and Meyskens, F. L., Jr. Retinoids as preventive and therapeutic anticancer agents. Cancer Treat. Rep., 71: 391-405 (part I), 493-515 (part II), 1987.
2. Jetten, A. M. Kim, J. S., Sacks, P. G., Rearick, J. I., Lotan, D., Hong, W. K., and Lotan, R. Suppression of growth and squamous cell differ-entiation markers in cultured human head and neck squamous carcinoma cells by beta-all trans retinoic acid. Int. J. Cancer, 45: 195-202, 1990.
3. Lotan, R. Suppression of squamous cell carcinoma growth and differentiation by retinoids. Cancer Res., 54: 1987s-1990s, 1994.
4. Bertram, J. S., Kolonel, L. N., and Meyskens, F. L., Jr. Rationale and strategies for chemoprevention of cancer in humans. Cancer Res., 47: 3012-3031, 1987.
5. Moon, R. C., and Mehta, R. G. Retinoid inhibition of experimental carcinogenesis. In: M. I. Dawson and W. H. Okamura (eds.), Chemistry and Biology of Synthetic Retinoids, pp. 501-518. Boca Raton, FL: CRC Press, 1990.
6. Pollard, M., Luckert, P., and Sporn, M. Prevention of primary prostate cancer in Loblund-Wistar rats by N-(4-hydroxyphenyl)retinamide. Cancer Res., 51: 3610-3611, 1991.
7. Shklar, G., Schwartz, J., Grau, D., Trickler, D., and Wallace, K. D. Inhibition of hamster buccal pouch carcinogenesis by 13-cis retinoic acid. Oral Surg., 50: 45-52, 1980.
8. Hill, D. L., and Grubbs, C. J. Retinoids as chemopreventive and anticancer agents in intact animals. Anticancer Res., 2: 111-124, 1982.
9. Abemayor, E. The effects of retinoic acid on the in vitro and in vivo growth of neuroblastoma cells. Laryngoscope, 102: 1133-1149, 1992.
10. Lippman, S. M. Kavanagh, J. J., Paredes-Espinoza, M., Delgadillo-Madrueno, F., Paredes-Casillas, P., Hong, W. K., Holdener, E., and Krakoff, I. H. 13-cis-retinoic acid plusiInterferon alpha-2a: a highly active systemic therapy for squamous cell carcinoma of the cervix. J. Natl. Cancer Inst., 84: 241-245, 1992.
11. Lippman, S. M., Kavanagh, J. J., Paredes-Espinoza, M., Delgadillo-Madrueno, F., Paredes-Casillas, P., Hong, W. K., Holdener, E., and Krakoff, I. H. 13-cis-retinoic acid plus interferon-alpha2a in locally advanced squamous cell carcinoma of the cervix. J. Natl. Cancer Inst., 85: 499-500, 1993.
12. Oikawa, T., Hirotani, K., Nakamura, O., Shudo, K., Hiragun, A., and Iwahuchi, T. A highly potent antiangiogenic activity of retinoids. Cancer Lett., 48: 157-162, 1989.
13. 3 analogues. Eur. J. Pharmacol., 178: 247-250, 1990.
14. 3 and their combination. Cancer Lett., 75: 35-39, 1993.
15. Majewski, S., Szmurlo, A., Marczak, M., Jablonska, S., and Bollag, W. Synergistic effects of retinoids and interferon alpha on tumor-induced angiogenesis; anti-angiogenic effect on HPV-harboring tumor-cell lines. Int. J. Cancer, 57: 81-85, 1994.
16. Zhang, L. X., Mills, K. J., Dawson, M. I., Collins, S. J., und Jetten, A. M. Evidence for the involvement of retinoic acid receptor RAR alpha-dependent signaling pathway in the induction of tissue transglutaminase and apoptosis by retinoids. J. Biol. Chem., 270: 6022-6029, 1995.
17. Nagy, L., Thomazy, V. A., Shipley, G. L., Fesus, L., Lamph, W., Heyman, R. A., Chandraratna, R. A., and Davies, P. J. Activation of retinoid X receptors induces apoptosis in HL-60 cell lines. Mol. Cell. Biol., 15: 3540-3551, 1995.
18. Alles A. J., and Sulik, K. K. Retinoic-acid-induced limb-reduction defects: perturbation of zones of programmed cell death as a pathogenetic mechanism. Teratology, 40: 163-171, 1989.
19. Lotan, R., Dawson, M. I., Zou, C. C., Jong, L., Lotan, D., and Zou, C. P. Enhanced efficacy of combinations of retinoic acid- and retinoid X receptor-selective retinoids and alpha-interferon in inhibition of cervical carcinoma cell proliferation. Cancer Res., 55: 232-236, 1995.
20. Lancillotti, F., Giandomenico, V., Affabris, E., Fiorucci, G., Romeo, G., and Rossi, G. B. Interferon alpha-2b and retinoic acid combined treatment affects proliferation and gene expression of human cervical carcinoma cells. Cancer Res., 55: 3158-3164, 1995.
21. Wu, D., Kan, M., Sato, G. H., Okamoto, T., and Sato J. D. Characterization and molecular cloning of a putative binding protein for heparinbinding growth factors. J. Biol. Chem., 266: 16778-16785, 1991.
22. Czubayko, F., Smith, R. V., Chung, H. C., and Wellstein, A. Tumor growth and angiogenesis induced by a secreted binding protein for fibroblast growth factors. J. Biol. Chem., 269: 28243-28248, 1994.
23. Liaudet-Coopman, E. D. E., and Wellstein, A. Regulation of gene expression of a binding protein for fibroblast growth factors by retinoic acid. J. Biol. Chem., 271: 21303-21308, 1996.
24. Schultz-Hector S., and Haghayegh S. Beta-fibroblast growth factor expression in human and murine squamous cell carcinomas and its relationship to regional endothelial cell proliferation. Cancer Res., 53: 1444-1449, 1993.
25. Agarwal, C., Rorke, E. A., Irwin, J. C., and Eckert, R. L. Immortalization by human papillomavirus type 16 alters retinoid regulation of human ectocervical epithelial cell differentiation. Cancer Res., 51: 3982-3989, 1991.
26. Lotan, R. Squamous cell differentiation markers in normal, premalignant and malignant epithelium: effects of retinoids. J. Cell. Biochem. 17F (Suppl.): 167-174, 1993.
27. Lippman, S. M., and Meyskens, F. L., Jr. Results of the use of vitamin A and retinoids in cutaneous malignancies. Pharmacol. Ther., 40: 107-122, 1989.
28. Weiner, S. A., Surwit, E. A., Graham, V. E., and Meyskens, F. L. Jr. A phase I trial of topically applied trans-retinoic acid in cervical dysplasia-clinical efficacy. Invest. New Drugs, 4: 241-244, 1986.
29. Graham, V., Surwit, E. S., Weiner, S., and Meyskens, F. L., Jr. Phase II trial of beta-all-tnans-retinoic acid for cervical intraepithelial neoplasia delivered via a collagen sponge and cervical cap. West J. Med., 145: 192-195, 1986.
30. Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst., 82: 4-6, 1990.
31. Ziehe, M., and Gullino, P. M. Angiogenesis and neoplastic progression in vitro. J. Natl. Cancer Inst., 69: 483-487, 1982.
32. Zheng, Z. S., Polakowska, R., Johnson, A., and Goldsmith, L. A. Transcriptional control of epidermal growth factor receptor by retinoic acid. Cell Growth & Differ., 3: 225-232, 1992.
33. Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., and Cheresh, D. A. Integrin alpha(v)beta(3) antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell, 79: 1157-1164, 1994.
34. Sacks, P. G., Oke, V., Calkins, D. P., Vasey, T., and Terry, N. H. A. Effects of beta-all-trans retinoic acid on growth, proliferation, and cell death in a multicellular tumor spheroid model for squamous carcinomas. J. Cell. Physiol., 144: 237-243, 1990.
35. Barr, P. J., and Tomei, L. D. Apoptosis and its role in human disease. Biotechnology, 12: 487-493, 1994.
36. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.